Cargando…

Probucol alleviates atherosclerosis and improves high density lipoprotein function

BACKGROUND: Probucol is a unique hypolipidemic agent that decreases high density lipoprotein cholesterol (HDL-C). However, it is not definite that whether probucol hinders the progression of atherosclerosis by improving HDL function. METHODS: Eighteen New Zealand White rabbits were randomly divided...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Jian-Kai, Guo, Zhi-Gang, Li, Chen, Wang, Zhen-Kun, Lai, Wen-Yan, Tu, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253062/ https://www.ncbi.nlm.nih.gov/pubmed/22078494 http://dx.doi.org/10.1186/1476-511X-10-210

Ejemplares similares

Rosiglitazone attenuates atherosclerosis and increases high-density lipoprotein function in atherosclerotic rabbits
por: LI, CHEN, et al.
Publicado: (2015)

High Density Lipoprotein-Based Therapeutics: Novel Mechanism of Probucol in Foam Cells
por: Hafiane, Anouar, et al.
Publicado: (2022)

Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits
por: Niimi, Manabu, et al.
Publicado: (2013)

Low-density lipoprotein particles in atherosclerosis
por: Qiao, Ya-Nan, et al.
Publicado: (2022)

Combined use of probucol and cilostazol with atorvastatin attenuates atherosclerosis in moderately hypercholesterolemic rabbits
por: Wang, Yanli, et al.
Publicado: (2015)

Acute Coronary Syndrome Remodels the Protein Cargo and Functions of High-Density Lipoprotein Subfractions
por: Tan, Ying, et al.
Publicado: (2014)

High density lipoproteins and atherosclerosis: emerging aspects
por: Sala, Federica, et al.
Publicado: (2012)

High density lipoprotein mimicking nanoparticles for atherosclerosis
por: Chen, Jun, et al.
Publicado: (2020)

Combination therapy of atorvastatin and probucol on ischemic stroke in clinic
por: Yan, Tao, et al.
Publicado: (2012)

New Evidence of Probucol on Cardiovascular Events
por: Hirata, Ken-ichi
Publicado: (2021)

Folic acid delays development of atherosclerosis in low‐density lipoprotein receptor‐deficient mice
por: Pan, Sunlei, et al.
Publicado: (2018)

Mechanisms underlying probucol-induced hERG-channel deficiency
por: Shi, Yuan-Qi, et al.
Publicado: (2015)

Oxidized low density lipoprotein, stem cells, and atherosclerosis
por: Yang, Hui, et al.
Publicado: (2012)

High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis
por: Ossoli, Alice, et al.
Publicado: (2016)

The Potential Role of Electronegative High-Density Lipoprotein H5 Subfraction in RA-Related Atherosclerosis
por: Chang, Ching-Kun, et al.
Publicado: (2021)

Low-Density Lipoprotein Cholesterol, Structural Atherosclerosis, and Functional Atherosclerosis in Older Japanese
por: Shimizu, Yuji, et al.
Publicado: (2022)

Circ_0065149 Alleviates Oxidized Low-Density Lipoprotein-Induced Apoptosis and Inflammation in Atherosclerosis by Targeting miR-330-5p
por: Li, Dan, et al.
Publicado: (2021)

Helicobacter pylori infection is associated with decreased serum levels of high density lipoprotein, but not with the severity of coronary atherosclerosis
por: Jia, En-Zhi, et al.
Publicado: (2009)

New Horizons for Probucol, an Old, Mysterious Drug
por: Yamashita, Shizuya, et al.
Publicado: (2021)

The Role of Oxidized Low-Density Lipoproteins in Atherosclerosis: The Myths and the Facts
por: Maiolino, Giuseppe, et al.
Publicado: (2013)

Mechanistic Insights into the Oxidized Low-Density Lipoprotein-Induced Atherosclerosis
por: Khatana, Chainika, et al.
Publicado: (2020)

Cysteamine Decreases Low‐Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low‐Density Lipoprotein Receptor–Deficient Mice
por: Ahmad, Feroz, et al.
Publicado: (2021)

Probucol Protects Against Atherosclerosis Through Lipid-lowering and Suppressing Immune Maturation of CD11c(+) Dendritic Cells in STZ-induced Diabetic LDLR(−/−) Mice
por: Zhu, Hong, et al.
Publicado: (2015)

Relationship between Concentration Difference of Different Density Lipoproteins and Shear Stress in Atherosclerosis
por: Meng, Wei, et al.
Publicado: (2012)

Successful Treatment of Diffuse Normolipemic Plane Xanthoma with Probucol
por: Miyagawa, Fumi, et al.
Publicado: (2013)

Probucol dramatically enhances dihydroartemisinin effect in murine malaria
por: Kume, Aiko, et al.
Publicado: (2016)

Probucol attenuates hyperoxia-induced lung injury in mice
por: Kawaguchi, Tomonobu, et al.
Publicado: (2017)

What Kind of Probucol Affects Normalizing Male Birth?
por: Komatsu, Tomohiro, et al.
Publicado: (2020)

Utility of Atherosclerosis Imaging in the Evaluation of High-Density Lipoprotein–Raising Therapies
por: Duivenvoorden, Raphaël, et al.
Publicado: (2011)

Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis
por: Hermansson, Andreas, et al.
Publicado: (2010)

Porphyromonas gingivalis accelerates atherosclerosis through oxidation of high-density lipoprotein
por: Kim, Hyun-Joo, et al.
Publicado: (2018)

Self-microemulsifying drug-delivery system for improved oral bioavailability of probucol: preparation and evaluation
por: Sha, Xianyi, et al.
Publicado: (2012)

Probucol Reduces Testicular Torsion/Detorsion-Induced Ischemia/Reperfusion Injury in Rats
por: Wei, Si-Ming, et al.
Publicado: (2017)

Effect of probucol on insulin resistance in patients with non-diabetic chronic kidney disease
por: Wang, Rui, et al.
Publicado: (2015)

Lipids and Lipoproteins in Atherosclerosis
por: Chroni, Angeliki, et al.
Publicado: (2011)

Lipids and Lipoproteins in Atherosclerosis
por: Bezsonov, Evgeny, et al.
Publicado: (2023)

Cysteamine inhibits lysosomal oxidation of low density lipoprotein in human macrophages and reduces atherosclerosis in mice
por: Wen, Yichuan, et al.
Publicado: (2019)

On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety
Publicado: (1995)

Oxidation of Low-Density Lipoprotein by Iron at Lysosomal pH: Implications for Atherosclerosis
por: Satchell, Leanne, et al.
Publicado: (2012)

Infusional high-density lipoproteins therapies as a novel strategy for treating atherosclerosis
por: Di Bartolo, Belinda A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_u59r58424v89ldnpe0l5lacg26